American Renal Associates Holdings Inc. (NYSE:ARA) went up by 66.47% from its latest closing price compared to the recent 1-year high of $10.60. The company’s stock price has collected 84.32% of gains in the last five trading sessions. Press Release reported on 10/02/20 that American Renal Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of American Renal Associates Holdings, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm — ARA
Is It Worth Investing in American Renal Associates Holdings Inc. (NYSE :ARA) Right Now?
Plus, the 36-month beta value for ARA is at 1.51. Opinions of the stock are interesting as 0 analysts out of 3 who provided ratings for American Renal Associates Holdings Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 3 rated it as “hold,” and 0 as “sell.”
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
The average price from analysts is $10.00, which is -$4.19 below the current price. ARA currently public float of 14.04M and currently shorts hold a 5.97% ratio of that float. Today, the average trading volume of ARA was 62.96K shares.
ARA’s Market Performance
ARA stocks went up by 84.32% for the week, with a monthly jump of 72.46% and a quarterly performance of 74.81%, while its annual performance rate touched 91.36%. The volatility ratio for the week stands at 4.17% while the volatility levels for the past 30 days are set at 4.15% for American Renal Associates Holdings Inc.. The simple moving average for the period of the last 20 days is 80.10% for ARA stocks with a simple moving average of 56.38% for the last 200 days.
Analysts’ Opinion of ARA
Deutsche Bank, on the other hand, stated in their research note that they expect to see ARA reach a price target of $12. The rating they have provided for ARA stocks is “Hold” according to the report published on January 03rd, 2019.
ARA Trading at 75.89% from the 50-Day Moving Average
After a stumble in the market that brought ARA to its low price for the period of the last 52 weeks, the company was able to rebound, for now settling with 8.68% of gains for the given period.
Volatility was left at 4.15%, however, over the last 30 days, the volatility rate increased by 4.17%, as shares surge +84.03% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +70.92% upper at present.
During the last 5 trading sessions, ARA rose by +84.32%, which changed the moving average for the period of 200-days by +17.43% in comparison to the 20-day moving average, which settled at $6.66. In addition, American Renal Associates Holdings Inc. saw 11.09% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for ARA
Current profitability levels for the company are sitting at:
- +10.02 for the present operating margin
- +21.12 for the gross margin
The net margin for American Renal Associates Holdings Inc. stands at -2.65. The total capital return value is set at 9.45, while invested capital returns managed to touch -4.14. Equity return is now at value 13.20, with -0.90 for asset returns.
Currently, EBITDA for the company is 36.00M with total debt to EBITDA at 4.86. When we switch over and look at the enterprise to sales, we see a ratio of 1.61, with the company’s debt to enterprise value settled at 0.55. The receivables turnover for the company is 8.03 and the total asset turnover is 0.79. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.15.